Home / Conferences / DIA 48th Annual US Meeting
DIA 48th Annual US Meeting Posted 08/12/2011
DIA 2012 is the largest multidisciplinary event that brings together a global network of professionals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, and medical products.
DIA 2012 features: Keynote speakers: Mr Dean Kamen, Inventor, Founder and President of DEKA Research & Development Corporation
‘If innovation is defined as moving ideas to value, then Dean Kamen defines innovation. His work brings health and wellness to those with disabilities, chronic diseases, and illnesses of the developing world. Dean’s remarks not only share his work, but the inspiration behind his work. I cannot imagine a better way to begin the learning cycle at the Annual Meeting.’ Register at www.diahome.org/diahome/FlagshipMeetings/home.aspx?meetingid=27170
- Mr Craig H Lipset, DIA 2012 Programme Chair
Comments (0)
Generics News Research General
- Clopidogrel goes off-patent: last of the old-st...Generics/General | Posted 18/05/2012
- Generic atorvastatin could save NHS GBP 350 mil...Generics/News | Posted 18/05/2012
- Can generic competition succeed at reducing cos...Generics/Research | Posted 11/05/2012
- Also noted on generics: 11 May 2012Generics/General | Posted 11/05/2012
Biosimilars News Research General
- Biosimilar filgrastim provides cost savings for...Biosimilars/Research | Posted 11/05/2012
- US Supreme Court looks set to challenge Afforda...Biosimilars/General | Posted 18/05/2012
- Biosimilars approved and marketed in BelgiumBiosimilars/General | Posted 18/05/2012
- Daiichi Sankyo and Coherus BioSciences make bio...Biosimilars/News | Posted 18/05/2012




